Warzok R - Search Results

1

Carbamazepine regulates intestinal P-glycoprotein and multidrug resistance protein MRP2 and influences disposition of talinolol in humans.

Giessmann T, May K, Modess C, Wegner D, Hecker U, Zschiesche M, Dazert P, Grube M, Schroeder E, Warzok R, Cascorbi I, Kroemer HK, Siegmund W. Giessmann T, et al. Among authors: warzok r. Clin Pharmacol Ther. 2004 Sep;76(3):192-200. doi: 10.1016/j.clpt.2004.04.011. Clin Pharmacol Ther. 2004. PMID: 15371980

2

Effect of levothyroxine administration on intestinal P-glycoprotein expression: consequences for drug disposition.

Siegmund W, Altmannsberger S, Paneitz A, Hecker U, Zschiesche M, Franke G, Meng W, Warzok R, Schroeder E, Sperker B, Terhaag B, Cascorbi I, Kroemer HK. Siegmund W, et al. Among authors: warzok r. Clin Pharmacol Ther. 2002 Sep;72(3):256-64. doi: 10.1067/mcp.2002.126706. Clin Pharmacol Ther. 2002. PMID: 12235446

3

The effects of the human MDR1 genotype on the expression of duodenal P-glycoprotein and disposition of the probe drug talinolol.

Siegmund W, Ludwig K, Giessmann T, Dazert P, Schroeder E, Sperker B, Warzok R, Kroemer HK, Cascorbi I. Siegmund W, et al. Among authors: warzok r. Clin Pharmacol Ther. 2002 Nov;72(5):572-83. doi: 10.1067/mcp.2002.127739. Clin Pharmacol Ther. 2002. PMID: 12426521

4

CYP2D6 genotype and induction of intestinal drug transporters by rifampin predict presystemic clearance of carvedilol in healthy subjects.

Giessmann T, Modess C, Hecker U, Zschiesche M, Dazert P, Kunert-Keil C, Warzok R, Engel G, Weitschies W, Cascorbi I, Kroemer HK, Siegmund W. Giessmann T, et al. Among authors: warzok r. Clin Pharmacol Ther. 2004 Mar;75(3):213-22. doi: 10.1016/j.clpt.2003.10.004. Clin Pharmacol Ther. 2004. PMID: 15001973

5

Intestinal expression of P-glycoprotein (ABCB1), multidrug resistance associated protein 2 (ABCC2), and uridine diphosphate-glucuronosyltransferase 1A1 predicts the disposition and modulates the effects of the cholesterol absorption inhibitor ezetimibe in humans.

Oswald S, Haenisch S, Fricke C, Sudhop T, Remmler C, Giessmann T, Jedlitschky G, Adam U, Dazert E, Warzok R, Wacke W, Cascorbi I, Kroemer HK, Weitschies W, von Bergmann K, Siegmund W. Oswald S, et al. Among authors: warzok r. Clin Pharmacol Ther. 2006 Mar;79(3):206-17. doi: 10.1016/j.clpt.2005.11.004. Epub 2006 Feb 7. Clin Pharmacol Ther. 2006. PMID: 16513445

6

Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans.

Vogelgesang S, Cascorbi I, Schroeder E, Pahnke J, Kroemer HK, Siegmund W, Kunert-Keil C, Walker LC, Warzok RW. Vogelgesang S, et al. Pharmacogenetics. 2002 Oct;12(7):535-41. doi: 10.1097/00008571-200210000-00005. Pharmacogenetics. 2002. PMID: 12360104

7

Modulation of multidrug resistance P-glycoprotein 1 (ABCB1) expression in human heart by hereditary polymorphisms.

Meissner K, Jedlitschky G, Meyer zu Schwabedissen H, Dazert P, Eckel L, Vogelgesang S, Warzok RW, Böhm M, Lehmann C, Wendt M, Cascorbi I, Kroemer HK. Meissner K, et al. Pharmacogenetics. 2004 Jun;14(6):381-5. doi: 10.1097/00008571-200406000-00007. Pharmacogenetics. 2004. PMID: 15247630

8

Disposition and antimuscarinic effects of the urinary bladder spasmolytics propiverine: influence of dosage forms and circadian-time rhythms.

May K, Westphal K, Giessmann T, Wegner D, Adam U, Lerch MM, Oertel R, Warzok RW, Weitschies W, Braeter M, Siegmund W. May K, et al. Among authors: warzok rw. J Clin Pharmacol. 2008 May;48(5):570-9. doi: 10.1177/0091270008315314. Epub 2008 Mar 4. J Clin Pharmacol. 2008. PMID: 18319360 Clinical Trial.

9

Induction of P-glycoprotein by rifampin increases intestinal secretion of talinolol in human beings: a new type of drug/drug interaction.

Westphal K, Weinbrenner A, Zschiesche M, Franke G, Knoke M, Oertel R, Fritz P, von Richter O, Warzok R, Hachenberg T, Kauffmann HM, Schrenk D, Terhaag B, Kroemer HK, Siegmund W. Westphal K, et al. Among authors: warzok r. Clin Pharmacol Ther. 2000 Oct;68(4):345-55. doi: 10.1067/mcp.2000.109797. Clin Pharmacol Ther. 2000. PMID: 11061574 Clinical Trial.

10

Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex.

Haenisch S, Zimmermann U, Dazert E, Wruck CJ, Dazert P, Siegmund W, Kroemer HK, Warzok RW, Cascorbi I. Haenisch S, et al. Among authors: warzok rw. Pharmacogenomics J. 2007 Feb;7(1):56-65. doi: 10.1038/sj.tpj.6500403. Epub 2006 Jun 20. Pharmacogenomics J. 2007. PMID: 16788565

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

161 results

Search Page

Filters